This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Excess cholesterol is known to form artery-clogging plaques that can lead to stroke, arterial disease, heartattack, and more, making it the focus of many heart health campaigns.
An analysis of data in the UK Biobank has found that COVID-19 infection may increase the risk of heartattack, stroke and death from any cause for up to three years for people with and without cardiovasculardisease, according to new research.
mg reduces the risk of major adverse cardiovascular events (MACE) and supports its use in the treatment of cardiovasculardisease. mg)has potential to directly reduce inflammation, which plays a substantial role in the formation and progression of atherosclerotic plaque leading to heartdisease, said Matthew J.
A recently unveiled cardiovasculardisease risk calculator that measures a patient's risk for heartattack and stroke is better calibrated and more precise than its previous version, but if current treatment guidelines for cholesterol and blood pressure therapy remain unchanged, the new calculator may have unintended consequences, according to research (..)
Researchers have discovered a better way of identifying those at high risk of potential heartattacks and strokes and other major cardiovasculardisease (CVD) events.
Researchers have identified a new target to treat atherosclerosis, a condition where plaque clogs arteries and causes major cardiac issues, including stroke and heartattack.
People with type 2 diabetes had significantly fewer heartattacks, strokes, heart failures, and deaths from cardiovasculardisease when their blood pressure was lower than the current standard goal, a UT Southwestern Medical Center researcher and his colleagues found.
Atherosclerotic cardiovasculardisease (ASCVD), caused by plaque buildup in arterial walls, is one of the leading causes of disability and death worldwide.1,2 1,2 ASCVD causes or contributes to conditions that include coronary artery disease (CAD), cerebrovascular disease, and peripheral vascular disease (inclusive of aortic aneurysm).3
(MedPage Today) -- The FDA approved semaglutide (Wegovy) to reduce the risk of cardiovascular death, heartattack, and stroke in adults with cardiovasculardisease and either obesity or overweight, the agency announced on Friday. A GLP-1 receptor.
Researchers from the Johns Hopkins Bloomberg School of Public Health have developed a single universal risk prediction model for cardiovasculardisease that, in initial tests, works well for patients who already have cardiovasculardisease as well as patients who do not but who may be at risk for developing it.
More than 70% of American Indian young adults aged 20-39 and 50% of American Indian teens have cholesterol levels or elevated fat in the blood that put them at risk for cardiovasculardisease, a new study suggests.
Taking a single pill that combines medications targeting cardiovasculardisease-related conditions was shown long ago to lower the risk of death from such causes, including heartattacks and strokes.
(MedPage Today) -- Various hormonal contraceptives were linked to incident cardiovasculardisease in an analysis of Denmark's nationwide records. From a pool of over 2 million women of reproductive age, users of most methods of hormonal contraception.
A review in The Lancet finds that 20% of the world population carries a genetic risk factor for cardiovasculardiseases such as heartattacks, strokes, and aortic valve stenosis: Increased levels of a lipid particle called lipoprotein(a). It is the most common genetic cause of cardiovasculardiseases.
Researchers have identified a new pathway that contributes to cardiovasculardisease associated with high levels of niacin, a common B vitamin previously recommended to lower cholesterol. The team discovered a link between 4PY, a breakdown product from excess niacin, and heartdisease.
However, for people with risks for heartdisease, these warning signals can have a negative consequence: they can increase the size of plaque in arteries, making them narrow, and trigger inflammatory events that can cause plaque to rupture. This can set the stage for a heartattack or stroke.
A projected rise in heartdisease and stroke – along with several key risk factors, including high blood pressure and obesity – is likely to triple related costs to $1.8 population could be affected by cardiovasculardisease within the next 30 years, according to two new science reports. to 61% of the U.S.
They will also selectively support clinical research involving the CaRi-Heart technology for coronary inflammation diagnostics and LODOCO 0.5 Caristo shares Agepha Pharma’s passion for fighting coronary inflammation, which is one of the primary drivers of heartattack risks,” said Frank Cheng , CEO of Caristo Diagnostics. “We
The answer is pretty simple, but most people get this wrong, and doing so increases their future risk of heartattack and strokes. We need to do better if we want to majorly impact rates of cardiovasculardisease worldwide. ” This is one of the most common questions I get as a cardiologist. Nat Rev Nephrol.
mg reduces the risk of major adverse cardiovascular events (MACE) and supports its use in the treatment of cardiovasculardisease. mg)has potential to directly reduce inflammation, which plays a substantial role in the formation and progression of atherosclerotic plaque leading to heartdisease, said Matthew J.
In simple terms, the higher your blood pressure, the higher the risk of a future heartattack or stroke. Even systolic (Top number) blood pressures of greater than 90 mmHg increase the risk of future heartdisease 2. So what constitutes ‘High’ blood pressure? This is it. No fancy procedures.
The lead investigators for the study are Dr. Kolossváry added, “The PRE-VUE registry will empower us to see the true additive value of CT-derived, histologically validated plaque volumes in predicting future adverse cardiovascular events.” 2017 23, April 2020; Available from: [link].
Recent guidelines have restricted aspirin use in the primary prevention of cardiovasculardisease. The American Heart Association (AHA)/American College of Cardiology (ACC) guidelines restricted aspirin to patients under 70, and more recently, the United States Preventive Services Task Force restricted aspirin use to patients under 60.
This refers to all the steps necessary to reduce the odds of a subsequent event, such as a second heartattack or stroke. So, let’s cover seven things that reduce the risk of a subsequent heartattack. This is a program that starts the day of your heartattack. Cardiac Rehabilitation.
Eighty percent of heartattacks and strokes are preventable. partially because its key risk factor, high blood pressure, is a ‘silent killer,’ and most patients have no symptoms before their first heartattack or stroke. Yet, CVD remains the leading cause of death in the U.S.,
Gerald and Myra Dorros Chair in CardiovascularDisease at Albert Einstein and serves as director of the Einstein Wilf Family Cardiovascular Research Institute.“Dr. His research is focused on cell death, particularly as it relates to heartdisease.
A study based on clinical trial data found higher risks of stroke, heartattack, and hospital admission for heart failure in older cancer survivors. In the analysis published in the journal Cancer, chemotherapy was also linked to elevated rates of these conditions.
The new model, which ultimately could change how cardiovasculardisease risk is assessed in doctors’ offices around the world, is described in a paper published online January 29 in the Journal of the American College of Cardiology. Parameters of the new model are available in the paper supplements.
Caristo Diagnostics Limited has announced the results of a landmark clinical study published in The Lancet that support the ability of Caristo's CaRi-Heart AI technology to quantify coronary artery inflammation and accurately predict cardiac events. Coronary inflammation is a crucial piece of the puzzle in predicting heartattack risk.
Smoking is a well-known health hazard, contributing to a wide array of diseases and conditions. Its effects on the heart are particularly alarming, as smoking significantly increases the risk of cardiovasculardiseases (CVDs) and complicates medical procedures such as minimally invasive or bloodless heart surgeries.
adults—and more than 2 in 5 adults aged 60 years and older—have elevated triglycerides, also known as hypertriglyceridemia , putting them at an increased risk for heartattacks and stroke. milla1cf Sun, 04/07/2024 - 18:20 April 7, 2024 — An estimated 1 in 5 U.S. and Canada. Patients’ median triglyceride level was 242 mg/dL.
Our findings show that interventions based on techniques from behavioral economics can achieve and sustain increased levels of physical activity in a population with risk factors for cardiovasculardisease and could be another tool to help reduce cardiovascular risk.”
Imagine a future where a silent, undetected heart condition is caught before it turns into a life-threatening event a future where artificial intelligence (AI) -powered insights alert clinicians to warning signs long before symptoms appear. Cardiovasculardisease (CVD) remains the leading cause of death in the U.S.
milla1cf Sun, 04/07/2024 - 18:09 April 7, 2024 — Among patients at high or very high risk for a heartattack or stroke, the addition of the investigational drug lerodalcibep to standard cholesterol-lowering medication for one year reduced LDL, or “bad” cholesterol, levels by more than half on average, compared with a placebo.
Zerlasiran is a siRNA (short interfering RNA) designed to lower the body’s production of Lp(a), a key genetic risk factor for cardiovasculardisease affecting up to 20% of the world’s population. In this case, it aims to ‘silence’ LPA, a gene that tells the body to make a specific protein that is only found in Lp(a).
Food and Drug Administration (FDA) for its PlaqueIQ imaging analysis software to help physicians diagnose cardiovasculardisease (CVD). Elucid has announced it received 510(k) clearance from the U.S. PlaqueIQ’s underpinnings in histology is a novel approach to the field of non-invasive coronary plaque classification,” said Dr.
Being heart healthy can prevent a heartattack or stroke by lowering your risk for heartdisease. To start you on the right path, there are several risk factors that doctors will tell you to focus on.
By varying the timing of heart beats for the upper and lower chambers, the new algorithm can lower blood pressure by several mechanisms and have a lasting benefit. Reducing high blood pressure lowers the risk of life-threatening strokes , heartattacks and cardiovasculardiseases.
Statement Highlights: The new American Heart Association PREVENTTM risk calculator estimates the 10- and 30-year risk of total cardiovasculardisease for people aged 30 years and older. The calculator estimates the risk of heartattack, stroke and —.
Research Highlights: In a large, international clinical trial, people with obesity or overweight but not diabetes taking semaglutide for more than 3 years had a 20% lower risk of heartattack, stroke or death due to cardiovasculardisease and lost an.
Drinking too much alcohol can lead to high blood pressure, a major risk factor for heartdisease. Studies show that repeated binge drinking can contribute to spikes in blood pressure, increasing the likelihood of stroke, heartattack, and heart failure.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content